Search for: "Gilead Sciences, Inc.,"
Results 61 - 80
of 181
Sort by Relevance
|
Sort by Date
6 Nov 2019, 9:15 am
Court of Appeals for the Federal Circuit (CAFC) decided an appeal by Idenix Pharmaceuticals LLC and Universita Degli Studi Di Cagliari (collectively “Idenix”) against Gilead Sciences, Inc. [read post]
6 Nov 2019, 9:15 am
Court of Appeals for the Federal Circuit (CAFC) decided an appeal by Idenix Pharmaceuticals LLC and Universita Degli Studi Di Cagliari (collectively “Idenix”) against Gilead Sciences, Inc. [read post]
30 Oct 2019, 10:48 pm
Gilead Sciences Inc., the Federal Circuit held that Idenix's patent was invalid on both grounds, affirming the District Court's overturning of a jury verdict on enablement and... [read post]
30 Oct 2019, 6:23 pm
Gilead Sciences Inc., (“Gilead”)argues that the patent is also invalid for failure to meet thewritten description requirement, and that the district courterred by failing to grant JMOL on that ground as well. [read post]
8 Apr 2019, 7:29 am
Gilead Sciences, Inc., the manufacturer of both medications, made them accessible through a newly created subsidiary, Asegua Therapeutics LLC. [read post]
3 Apr 2019, 5:15 am
Moreover, the Federal Circuit, in Gilead Sciences, Inc. v. [read post]
7 Feb 2019, 12:08 pm
First, in an amicus brief filed in opposition to a petition for certiorari in Gilead Sciences, Inc. v. [read post]
30 Jan 2019, 10:15 am
A sensible ruling, and one the panel explained was entirely consistent with both the PTA statute and Gilead Sciences, Inc. v. [read post]
23 Jan 2019, 8:28 am
District Court for the Eastern District of Virginia.The district court determined that, based on thiscourt’s decision in Gilead Sciences, Inc. v. [read post]
17 Jan 2019, 6:50 am
Anders ValentinGilead Sciences vs Sandoz – Round One The history of the case started in 2018, where Gilead Sciences Inc., brought preliminary injunctions before the court against several companies. [read post]
21 Dec 2018, 2:15 am
Applying the Federal Circuit case Gilead Sciences, Inc. v. [read post]
21 Dec 2018, 2:15 am
Applying the Federal Circuit case Gilead Sciences, Inc. v. [read post]
20 Dec 2018, 10:14 am
In Gilead Sciences, Inc. v. [read post]
9 Dec 2018, 9:59 pm
That question was whether its decision in Gilead Sciences Inc. v. [read post]
5 Dec 2018, 2:15 pm
In Gilead Sciences Inc. v. [read post]
23 Oct 2018, 2:00 pm
Gilead Sciences Inc. 18-378 Issue: Whether the equitable defense of unclean hands precludes legal relief in the form of damages. [read post]
11 Oct 2018, 12:57 am
Eszter SzakácsCo-author: Zsolt Lengyel, Danubia Patent and Law Office Just a few months before the CJEU’s judgment in C-121/17 Teva UK Ltd and Others v Gilead Sciences Inc. came out a the Metropolitan Court of Budapest handed down a decision regarding Merck Sharp and Dohme Corp’s (MSD) application for an SPC re the combination of ezetimibe and rosuvastatin. [read post]
4 Oct 2018, 12:49 pm
Gilead Sciences Inc., facing steep competition from other makers and innovations from non-profits, has decided to sell cheaper, just as potent versions of its hep C fighting drugs Epclusa and Harvoni. [read post]
26 Sep 2018, 6:00 pm
Gilead Sciences, Inc., Docket No. 18-378 (Supreme Court 2018) In its newly filed petition for writ of certiorari, Merck asks one simple question: Whether the equitable defense of unclean hands precludes legal relief in the form of damages. [read post]
31 Aug 2018, 10:21 am
Serco, Inc. and United States ex rel. [read post]
